Han Han

Person

Belmont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of use of emulsion formulations of an NK-1 receptor antagonist
- Patent number 12,115,254
- Issue date Oct 15, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Methods of use of emulsion formulations of an NK-1 receptor antagonist
- Patent number 12,115,255
- Issue date Oct 15, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Methods of use of emulsion formulations of an NK-1 receptor antagonist
- Patent number 11,878,074
- Issue date Jan 23, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of use of emulsion formulations of an NK-1 receptor antagonist
- Patent number 11,744,800
- Issue date Sep 5, 2023
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Targeted nanoparticles
- Patent number 11,285,212
- Issue date Mar 29, 2022
- California Institute of Technology
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
- Patent number 11,173,118
- Issue date Nov 16, 2021
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 10,953,018
- Issue date Mar 23, 2021
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
- Patent number 10,624,850
- Issue date Apr 21, 2020
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 10,500,208
- Issue date Dec 10, 2019
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted nanoparticles
- Patent number 10,166,291
- Issue date Jan 1, 2019
- California Institute of Technology
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
- Patent number 9,974,742
- Issue date May 22, 2018
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 9,974,793
- Issue date May 22, 2018
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 9,974,794
- Issue date May 22, 2018
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 9,808,465
- Issue date Nov 7, 2017
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Emulsion formulations of aprepitant
- Patent number 9,561,229
- Issue date Feb 7, 2017
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeted nanoparticles
- Patent number 9,468,681
- Issue date Oct 18, 2016
- California Institute of Technology
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticles stabilized with nitrophenylboronic acid compositions
- Patent number 9,446,149
- Issue date Sep 20, 2016
- California Institute of Technology
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nanoparticles stabilized with nitrophenylboronic acid compositions
- Patent number 9,132,097
- Issue date Sep 15, 2015
- California Institute of Technology
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
- Publication number 20240238197
- Publication date Jul 18, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
- Publication number 20240148650
- Publication date May 9, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT
- Publication number 20240139201
- Publication date May 2, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
- Publication number 20240139106
- Publication date May 2, 2024
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
- Publication number 20230072781
- Publication date Mar 9, 2023
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
TARGETED NANOPARTICLES
- Publication number 20210283258
- Publication date Sep 16, 2021
- California Institute of Technology
- MARK E. DAVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT
- Publication number 20210186981
- Publication date Jun 24, 2021
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
- Publication number 20210173877
- Publication date Jun 10, 2021
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Application
EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF
- Publication number 20200383914
- Publication date Dec 10, 2020
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20200197404
- Publication date Jun 25, 2020
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Targeted Nanoparticles
- Publication number 20190117773
- Publication date Apr 25, 2019
- California Institute of Technology
- MARK E. DAVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF
- Publication number 20190000762
- Publication date Jan 3, 2019
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20180000829
- Publication date Jan 4, 2018
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20180000828
- Publication date Jan 4, 2018
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETED NANOPARTICLES
- Publication number 20170296665
- Publication date Oct 19, 2017
- California Institute of Technology
- MARK E. DAVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF
- Publication number 20170216205
- Publication date Aug 3, 2017
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20170112847
- Publication date Apr 27, 2017
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYMER-BASED COMPOSITIONS FOR EXTENDED RELEASE OF PROTEINS
- Publication number 20160324798
- Publication date Nov 10, 2016
- Han Han
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20160206622
- Publication date Jul 21, 2016
- Heron Therapeutics Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EMULSION FORMULATIONS OF APREPITANT
- Publication number 20160082013
- Publication date Mar 24, 2016
- Heron Therapeutics, Inc.
- Thomas B. Ottoboni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS
- Publication number 20160000934
- Publication date Jan 7, 2016
- Mark E. Davis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS
- Publication number 20140249203
- Publication date Sep 4, 2014
- Mark E. Davis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED NANOPARTICLES
- Publication number 20140249202
- Publication date Sep 4, 2014
- Mark E. Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Methods of use of emulsion formulations of an NK-1 receptor antagonist

Methods of use of emulsion formulations of an NK-1 receptor antagonist

Methods of use of emulsion formulations of an NK-1 receptor antagonist

Methods of use of emulsion formulations of an NK-1 receptor antagonist

Targeted nanoparticles

Emulsion formulations of an NK-1 receptor antagonist and uses thereof

Emulsion formulations of aprepitant

Emulsion formulations of an NK-1 receptor antagonist and uses thereof

Emulsion formulations of aprepitant

Targeted nanoparticles

Emulsion formulations of an NK-1 receptor antagonist and uses thereof

Emulsion formulations of aprepitant

Emulsion formulations of aprepitant

Emulsion formulations of aprepitant

Emulsion formulations of aprepitant

Targeted nanoparticles

Nanoparticles stabilized with nitrophenylboronic acid compositions

Nanoparticles stabilized with nitrophenylboronic acid compositions

Patents Applicationslast 30 patents

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

TARGETED NANOPARTICLES

METHODS OF USE OF EMULSION FORMULATIONS OF APREPITANT

METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST

EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF

EMULSION FORMULATIONS OF APREPITANT

Targeted Nanoparticles

EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF

EMULSION FORMULATIONS OF APREPITANT

EMULSION FORMULATIONS OF APREPITANT

TARGETED NANOPARTICLES

EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST AND USES THEREOF

EMULSION FORMULATIONS OF APREPITANT

POLYMER-BASED COMPOSITIONS FOR EXTENDED RELEASE OF PROTEINS

EMULSION FORMULATIONS OF APREPITANT

EMULSION FORMULATIONS OF APREPITANT

NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS

NANOPARTICLES STABILIZED WITH NITROPHENYLBORONIC ACID COMPOSITIONS

TARGETED NANOPARTICLES